Related Experiment Videos
[Definitions and recommendations for studying the delay of antidepressant action. Part 3: methodological aspects]
C S Peretti1, P Martin, F Bayle
1Service de Psychiatrie des Adultes, CHU de Reims, Hôpital Robert-Debré, avenue du Général Koenig, 51092 Reims cedex.
L'Encephale
|November 15, 2003
Summary
Establishing the time of response to antidepressants lacks clear criteria, necessitating a consensus on assessment methods for effective depression treatment. Further research is needed to refine these pharmacological and clinical approaches.
Area of Science:
- Psychiatry and Pharmacology
- Clinical Neuroscience
- Evidence-Based Medicine
Context:
- Antidepressant efficacy is crucial for treating major depressive disorder.
- Current assessment of antidepressant response time lacks standardized criteria.
- Expert consensus is needed to guide research and clinical practice.
Purpose:
- To review and synthesize literature on the time of response to antidepressants.
- To identify consensus and discrepancies in pharmacological, clinical, and methodological aspects.
- To propose recommendations for future research on antidepressant response.
Summary:
- No definitive pharmacological criteria exist for assessing antidepressant response time due to depression's complexity.
- Assessment criteria vary based on quantitative (global) or qualitative (symptomatic) approaches.
- Consensus exists on using placebo comparators, but active references depend on patient populations.
Impact:
- Highlights the need for standardized methods to evaluate antidepressant efficacy.
- Suggests integrating cognitive symptoms into assessment tools for improved diagnosis.
- Informs the development of more precise clinical trials and treatment guidelines.